Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

92.14 +1.21 (+1.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
72 73 Next >
News headline image
The 3 Most Undervalued Pharma Stocks to Buy in September 2023 ↗
Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now. 
Via InvestorPlace
News headline image
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite. 
Via Investor's Business Daily
News headline image
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits ↗
The U.S. 
Via Benzinga
News headline image
BioNTech Unusual Options Activity For August 30 ↗
 
Via Benzinga
News headline image
Expert Ratings for BioNTech ↗
 
Via Benzinga
News headline image
BioNTech Unusual Options Activity For August 21 ↗
 
Via Benzinga
News headline image
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry ↗
On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the... 
Via Benzinga
News headline image
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant ↗
Pirola has about 30 mutations compared with previous omicron versions of the virus. 
Via Investor's Business Daily
News headline image
3 Stocks to Buy For the COVID Resurgence
The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting 
Via MarketBeat
News headline image
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle ↗
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'... 
Via Benzinga
News headline image
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal ↗
Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet... 
Via Talk Markets
News headline image
Jeff Bezos Vs. Elon Musk Space Contract Lawsuit, Novo Nordisk's Famed Drug Ozempic Could Be Next Contender For Medicare Negotiations, Tesla Rival XPeng's August Deliveries Zooms 43%: Today's Top Stories ↗
Tech Crunch 
Via Benzinga
Topics Lawsuit
News headline image
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns ↗
The European Commission has approved Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech SE (NASDAQ: 
Via Benzinga
News headline image
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
From BioNTech SE
Via GlobeNewswire
News headline image
Why Novavax Stock Was So Healthy on Monday ↗
As the coronavirus threat rises, so too does the vaccine maker's value to investors. 
Via The Motley Fool
News headline image
Why BioNTech Shares Are Rising During Monday's Session ↗
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by some 2.25% to $120.26 Monday. The stock is gaining today amid rising COVID-19 cases in the U.S. 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
 
Via Benzinga
News headline image
COVID Is Making a Comeback: Should You Buy These 2 Stocks? ↗
Can these companies keep up their recent momentum? 
Via The Motley Fool
News headline image
Novavax (NVAX) Stock Is Getting Ready to Rally Again ↗
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot. 
Via InvestorPlace
News headline image
Why Moderna, BioNTech SE, and Novavax Surged Today ↗
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign. 
Via The Motley Fool
News headline image
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33. 
Via Benzinga
News headline image
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58.... 
Via Benzinga
Topics Stocks
News headline image
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance ↗
The companies are hoping to launch their updated Covid shots in September. 
Via Investor's Business Daily
News headline image
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies ↗
Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies... 
Via Benzinga
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors. 
Via InvestorPlace
News headline image
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
From BioNTech SE
Via GlobeNewswire
News headline image
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership ↗
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies... 
Via Talk Markets
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.